Position in LKFT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,696,298
+$335,168 QoQ
Shares Held
56,581
+24.7% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 78 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LKFT Over Time
Shares Held
Position Value (USD)
Derivatives in LKFT
reported options exposure · as of Sep 30, 2022CallValue
$1,066,000
CallShares
25,000
PutValue
$1,066,000
PutShares
25,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,039,430,805 across 359 Biotechnology names. LKFT ranks #235 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in LKFT
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,696,298 | 56,581 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,361,130 | 45,371 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $364,408 | 11,144 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $2,291,124 | 66,141 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,587,900 | 56,731 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $680,102 | 24,731 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,497,598 | 52,018 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,978,311 | 79,835 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,945,817 | 91,485 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,840,805 | 119,085 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $2,597,019 | 75,167 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $1,065,657 | 26,209 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $1,640,074 | 42,445 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,821,192 | 63,569 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $1,066,000 | 25,000 | Put | Defined | 2024-05-14 | |
| 2022-09-30 | $1,066,000 | 25,000 | Call | Defined | 2024-05-14 | |
| 2022-09-30 | $1,867,759 | 43,803 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $1,106,681 | 19,833 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $3,907,135 | 62,998 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,240,425 | 22,500 | Call | Defined | 2022-02-17 | |
| 2021-12-31 | $4,200,078 | 76,185 | Shares | Defined | 2022-02-17 | |
| 2021-12-31 | $1,240,425 | 22,500 | Put | Defined | 2022-02-17 | |
| 2021-09-30 | $1,309,989 | 24,900 | Put | Defined | 2022-01-20 | |
| 2021-09-30 | $1,309,989 | 24,900 | Call | Defined | 2022-01-20 | |
| 2021-09-30 | $3,318,901 | 63,085 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $4,535,992 | 65,844 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $20,050,106 | 260,087 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,402,634 | 34,377 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,788,207 | 12,601 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,161,042 | 21,091 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $5,102,932 | 26,046 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||